Using a Discrete-Choice Experiment in a Decision Aid to Nudge Patients Towards Value-Concordant Treatment Choices in Rheumatoid Arthritis: A Proof-of-Concept Study by Hazlewood GS, Marshall DA, Barber CEH, Li LC, Barnabe C, Bykerk V, Tugwell P, Hull PM, Bansback N

Get full text

Disruptive innovation in rheumatology: new networks of global public-private partnerships are needed to take advantage of scientific progress. by Huizinga, TW, Holers, VM, Anolik, J, Brenner, MB, Buckley, CD, Bykerk, V, Connolly, SE, Deane, KD, Guo, J, Hodge, M, Hoffmann, S, Nestle, F, Pitzalis, C, Raychaudhuri, S, Yamamoto, K, Li, Z, Klareskog, L

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update by Smolen, J, Landewé, R, Bijlsma, J, Burmester, G, Chatzidionysiou, K, Dougados, M, Nam, J, Ramiro, S, Voshaar, M, van Vollenhoven, R, Aletaha, D, Aringer, M, Boers, M, Buckley, C, Buttgereit, F, Bykerk, V, Cardiel, M, Combe, B, Cutolo, M, van Eijk-Hustings, Y, Emery, P, Finckh, A, Gabay, C, Gomez-Reino, J, Gossec, L, Gottenberg, J, Hazes, J, Huizinga, T, Jani, M, Karateev, D, Kouloumas, M, Kvien, T, Li, Z, Mariette, X, McInnes, I, Mysler, E, Nash, P, Pavelka, K, Poór, G, Richez, C, van Riel, P, Rubbert-Roth, A, Saag, K, da Silva, J, Stamm, T, Takeuchi, T, Westhovens, R, de Wit, M, van der Heijde, D